Characterization of CD56bright NK cells in daclizumab HYP-treated RRMS patients Huss DJ, Fragoso MF, Cullen P, Allaire N, Naughton B, Bienkowska J, Fontenot JD ACTRIMS-ECTRIMS 2014. 09/12/2014. CommentRecommendBookmarkWatch
